Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who are male and aged 19 years or older
- People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy)
- People whose prostate cancer has continued to grow despite hormone-reducing treatment (known as castration-resistant prostate cancer)
- People whose general health and ability to carry out daily activities meets a certain minimum level, as rated by a standard medical scale (ECOG score of 2 or less — confirm with trial site)
- People who have previously been treated with a chemotherapy drug called docetaxel
- People who have a recent PSA (prostate-specific antigen) blood test result available
- People whose cancer can be measured or assessed using standard imaging guidelines (confirm with trial site)
Who may not be able to join:
- People who have been diagnosed with another type of cancer within the past 3 years (other than prostate cancer)
- People who have had an organ transplant at any point in the past
- People whose prostate cancer still responds to standard hormone-reducing treatment (hormone-sensitive prostate cancer)
- People whose general health falls below a certain level on the standard medical rating scale (ECOG score of 3 or higher — confirm with trial site)
- People who have not previously been treated with docetaxel
- People who have previously been treated with a chemotherapy drug called ifosfamide
- People who do not have a PSA blood test result available
- People whose cancer cannot be measured or assessed using standard imaging guidelines (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sang Joon Shin, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine
Phone: 82-2-2228-8130
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.